CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Nyxoah Q3 net loss narrows 24% to EUR 17.83 million

By Public Technologies
  • Nyxoah's third-quarter 2026 net loss narrowed 24% year-over-year to €17.83 million, while revenue rose to €9.17 million.
  • Nine-month selling, general and administrative expenses climbed 31% to €47.01 million due to higher U.S. commercialization and IP litigation costs.
  • The ACCCESS study met its primary safety and efficacy endpoints; preparations are underway for an FDA submission expanding Genio's indication.
  • The company expects sales to continue ramping up primarily in the United States during 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nyxoah SA published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk